High Risk for Rare Autosomal Trisomies Detected by Non‐Invasive Prenatal Testing: Prenatal Diagnosis and Pregnancy Outcomes
Prenatal Diagnosis · 2026
DOI: 10.1002/pd.70181 ↗At a glance
Journal article in Prenatal Diagnosis, 2026. Written by Zihan Jiang and 9 co-authors. Institution: Center for Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Major MEDLINE topics: Trisomy, Noninvasive Prenatal Testing, Prenatal Diagnosis. 30 references. Funded by: Clinical Trials from Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Jiangsu Provincial Obstetrics and Gynecology Innovation Center.
Abstract (original language)
Objective
To investigate the incidence, positive predictive value (PPV) and pregnancy outcomes of rare autosomal trisomies (RATs) identified by non‐invasive prenatal testing (NIPT).
Method
A retrospective analysis of pregnancies who underwent NIPT at our center between May 2020 and August 2024 and received high‐risk RATs results. A copy number (CN) ≥ 2.4 indicated high‐risk for maternal duplications, while a CN ≤ 1.6 correlated with maternal deletion. Targeted amplicon sequencing was utilized to screen for uniparental disomy (UPD)‐related imprinting disorders. Prenatal diagnosis and pregnancy outcome follow‐up were recommended for all high‐risk pregnancies.
Results
Among 20,796 pregnancies screened, 0.26% (55/20,796) were identified as high‐risk for RATs. Prenatal diagnosis was performed in 44 cases, with a PPV of 4.55%. Maternal copy number variations were confirmed in four cases, three of which were transmitted to the fetus. No UPD‐related imprinting disorders were detected in the 23 cases. Two cases of mosaic trisomy showed similar levels of mosaicism on chromosomal microarray analysis (CMA) but had divergent clinical outcomes. Among 36 cases with no abnormalities detected by prenatal CMA, 38.89% had adverse outcomes.
Conclusion
NIPT for RATs has a low PPV, but the risk of adverse outcomes is high. Mosaic RATs identified via amniocyte‐based prenatal diagnosis do not always correlate with an obvious postnatal phenotype. Integrating prenatal diagnosis with ultrasound monitoring is essential for fetal prognosis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Center for Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- Department of Obstetrics & Gynecology, The Chinese University of Hong Kong, Hong Kong SAR, China.
ORCID profiles: Zihan Jiang, Wei Liu
Funding
- Clinical Trials from Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
- Jiangsu Provincial Obstetrics and Gynecology Innovation Center
Cite
APA
Jiang, Z., Wang, W., Zhang, Y., Zhu, X., Liu, W., Gu, L., Xu, Q., Zhu, Y., Li, J., & Duan, H. (2026). High Risk for Rare Autosomal Trisomies Detected by Non‐Invasive Prenatal Testing: Prenatal Diagnosis and Pregnancy Outcomes. Prenatal Diagnosis. https://doi.org/10.1002/pd.70181
Vancouver
Jiang Z, Wang W, Zhang Y, Zhu X, Liu W, Gu L, et al. High Risk for Rare Autosomal Trisomies Detected by Non‐Invasive Prenatal Testing: Prenatal Diagnosis and Pregnancy Outcomes. Prenatal Diagnosis. 2026. doi:10.1002/pd.70181
BibTeX
@article{Jiang2026,
author = {Jiang, Zihan and Wang, Wanjun and Zhang, Ying and Zhu, Xiangyu and Liu, Wei and Gu, Leilei and Xu, Qiqi and Zhu, Yujie and Li, Jie and Duan, Honglei},
title = {High Risk for Rare Autosomal Trisomies Detected by Non‐Invasive Prenatal Testing: Prenatal Diagnosis and Pregnancy Outcomes},
journal = {Prenatal Diagnosis},
year = {2026},
doi = {10.1002/pd.70181}
}
EUVIMED